Genome-wide Survival Study Identifies PARL as a Novel Locus for Clinical Progression and Neurodegeneration in Alzheimer’s Disease

[1]  Nick C Fox,et al.  New insights into the genetic etiology of Alzheimer’s disease and related dementias , 2022, Nature Genetics.

[2]  D. Geschwind,et al.  Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration , 2022, Cell.

[3]  S. DeKosky,et al.  Genome‐wide meta‐analysis of age‐related cognitive decline in population‐based older individuals , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[4]  Laurent F. Thomas,et al.  A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease , 2021, Nature Genetics.

[5]  W. M. van der Flier,et al.  Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity , 2021, Neurology.

[6]  O. Hansson,et al.  Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[7]  R. Barker,et al.  Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease , 2021, Nature Genetics.

[8]  Daniel J. Gaffney,et al.  Genome-wide meta-analysis, fine-mapping, and integrative prioritization implicate new Alzheimer’s disease risk genes , 2021, Nature Genetics.

[9]  Sonja W. Scholz,et al.  Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study , 2020, The Lancet Neurology.

[10]  M. Mattson,et al.  Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing , 2020, Nature Reviews Drug Discovery.

[11]  Muhammad Naveed Iqbal Qureshi,et al.  18F-MK-6240 PET for early and late detection of neurofibrillary tangles. , 2020, Brain : a journal of neurology.

[12]  Seunggeun Lee,et al.  A Fast and Accurate Method for Genome-Wide Time-to-Event Data Analysis and Its Application to UK Biobank. , 2020, American journal of human genetics.

[13]  R. Green,et al.  Genome‐wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[14]  M. J. Lemieux,et al.  PARL Protease: A Glimpse at Intramembrane Proteolysis in the Inner Mitochondrial Membrane. , 2020, Journal of molecular biology.

[15]  J. Trojanowski,et al.  Predicting clinical decline and conversion to Alzheimer’s disease or dementia using novel Elecsys Aβ(1–42), pTau and tTau CSF immunoassays , 2019, Scientific Reports.

[16]  Benjamin A. Logsdon,et al.  Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age , 2019, Nature Communications.

[17]  Timothy J. Hohman,et al.  Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk , 2019, Nature Genetics.

[18]  Amaia M. Arranz,et al.  PARL deficiency in mouse causes Complex III defects, coenzyme Q depletion, and Leigh-like syndrome , 2018, Proceedings of the National Academy of Sciences.

[19]  A. Fagan,et al.  Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging , 2018, Alzheimer's & Dementia.

[20]  P. Donnelly,et al.  The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.

[21]  B. Miller,et al.  Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders , 2018, JAMA.

[22]  Albert Hofman,et al.  The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study , 2018, The Lancet Neurology.

[23]  C. Jack,et al.  NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.

[24]  Anne Brækhus,et al.  Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics. , 2018, Journal of Alzheimer's disease : JAD.

[25]  D. Posthuma,et al.  Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.

[26]  M. Weiner,et al.  Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons , 2017, JAMA.

[27]  David M. Evans,et al.  Collider scope: when selection bias can substantially influence observed associations , 2016, bioRxiv.

[28]  T. Langer,et al.  PARL mediates Smac proteolytic maturation in mitochondria to promote apoptosis , 2017, Nature Cell Biology.

[29]  B. Ueberheide,et al.  Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer’s disease , 2017, Acta Neuropathologica.

[30]  K. Blennow,et al.  Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid , 2016, Alzheimer's & Dementia.

[31]  David A. Knowles,et al.  RNA splicing is a primary link between genetic variation and disease , 2016, Science.

[32]  P. Visscher,et al.  Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets , 2016, Nature Genetics.

[33]  Chelsea Sanders,et al.  Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study1. , 2016, Journal of Alzheimer's disease : JAD.

[34]  H. Lorenz,et al.  Intramembrane protease PARL defines a negative regulator of PINK1- and PARK2/Parkin-dependent mitophagy , 2015, Autophagy.

[35]  S. Quake,et al.  A survey of human brain transcriptome diversity at the single cell level , 2015, Proceedings of the National Academy of Sciences.

[36]  Joris M. Mooij,et al.  MAGMA: Generalized Gene-Set Analysis of GWAS Data , 2015, PLoS Comput. Biol..

[37]  Robert C. Green,et al.  Genome-wide association study of the rate of cognitive decline in Alzheimer's disease , 2014, Alzheimer's & Dementia.

[38]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[39]  John C. Morris,et al.  Progression of Alzheimer’s disease as measured by Clinical Dementia Rating Sum of Boxes scores , 2013, Alzheimer's & Dementia.

[40]  Philip S. Insel,et al.  Development and assessment of a composite score for memory in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) , 2012, Brain Imaging and Behavior.

[41]  M. Mintun,et al.  Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects , 2012, The Journal of Nuclear Medicine.

[42]  J. Schneider,et al.  National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.

[43]  H. Soares,et al.  Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment , 2011, Translational Psychiatry.

[44]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[45]  S. Potkin,et al.  Genome-wide association study of CSF biomarkers Aβ1-42, t-tau, and p-tau181p in the ADNI cohort , 2010, Neurology.

[46]  Nick C Fox,et al.  The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.

[47]  R. D'Hooge,et al.  Mitochondrial Rhomboid PARL Regulates Cytochrome c Release during Apoptosis via OPA1-Dependent Cristae Remodeling , 2006, Cell.

[48]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[49]  A. Dale,et al.  Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.

[50]  E. Koonin,et al.  PAMP and PARL, two novel putative metalloproteases interacting with the COOH-terminus of Presenilin-1 and -2. , 2001, Journal of Alzheimer's disease : JAD.

[51]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.